Role of gut microbiome in the outcome of cancer immunotherapy
Authors:
- 18 February 2021
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 149 (4) , 760-768
Abstract
Nearly 3 × 1013 types of bacteria colonize the human intestine. These colonized bacteria help in maintaining intestinal homeostasis by establishing a complex relationship with the intestinal epithelium and lymphoid tissue. Alteration in the composition of the intestinal microbiota is associated with susceptibility to various pathological conditions, such as autoimmune disorders, diabetes, inflammation and cancer. Of late, several researchers have focused on examining the effects of gut microbiota on the outcome of various cancer treatment protocols. Side effects and complications of traditional chemotherapy and allogeneic hematopoietic cell transplantation are associated with intestinal dysbiosis. Gut microbiota affects the efficacy of immune checkpoint inhibitor‐based immunotherapy. The gut is inhabited by diverse resident bacteria, of which, few enhance, while others inhibit the host response to immunotherapy. This review focuses on the correlation between intestinal microbiota and the outcome of tumor immunotherapy. Additionally, the molecular mechanisms underlying the effects of gut microbiota on the efficacy of cancer immunotherapy have been reviewed. Further studies are needed for the identification of distinct gut microbiota and their efficacy in tumor immunotherapy as certain types of intestinal bacteria could function as novel adjuvant drugs to enhance the effectiveness of antitumor therapy in humans.Keywords
This publication has 65 references indexed in Scilit:
- Diet-Microbiota Interactions and Their Implications for Healthy LivingNutrients, 2013
- Intestinal microbiota: Shaping local and systemic immune responsesSeminars in Immunology, 2012
- Peripheral education of the immune system by colonic commensal microbiotaNature, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiotaProceedings of the National Academy of Sciences, 2010
- Beneficial effects of Bacteroides fragilis polysaccharides on the immune systemFrontiers in Bioscience-Landmark, 2010
- The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteriaGut Microbes, 2010
- Control of Regulatory T Cell Lineage Commitment and MaintenanceImmunity, 2009
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJournal of Experimental Medicine, 2006
- Principles and use of anti-CTLA4 antibody in human cancer immunotherapyCurrent Opinion in Immunology, 2006